{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Mineralys Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"MLYS"},"Address":{"label":"Address","value":"150 N. RADNOR CHESTER RD.,SUITE F200, RADNOR, Pennsylvania, 19087, United States"},"Phone":{"label":"Phone","value":"8883786240.0"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania."},"CompanyUrl":{"label":"Company Url","value":"https://mineralystx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Cindy Berejikian","title":"Executive Vice President-Operations"},{"name":"David M. Rodman","title":"Chief Medical Officer"},{"name":"Jessica Ibbitson","title":"Senior Vice President-Clinical Operations"},{"name":"Jon Congleton","title":"Chief Executive Officer & Director"},{"name":"Stephen Djedjos","title":"Senior Vice President-Clinical Development"},{"name":"Tiffany Burt","title":"Vice President-Medical Affairs"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}